animenews: Regulus hep C combination drug effective in mid-stage study

Affichage des articles dont le libellé est Regulus hep C combination drug effective in mid-stage study. Afficher tous les articles

mercredi 17 février 2016

Regulus hep C combination drug effective in mid-stage study

(Reuters) - Regulus Therapeutics Inc said interim data showed that patients tested with its hepatitis C drug combination treatment displayed sustained viral response in an ongoing mid-stage study, sending its shares up 43 percent in premarket trading.